Build back better: US pharma and the future of healthcare
pharmaphorum
JULY 19, 2021
Now, as vaccination continues at pace, the sector has pledged to help “build back better”, by lowering barriers between medical innovations and the patients who need them. In addition, people on ventilators or with weakened immune systems have been at risk of secondary infections, which has further driven up use of antimicrobials.
104 
Let's personalize your content